Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 23.89% is 45% above its 5-year average of 16.45%, near the high end of its 5-year range (10.45%–23.89%).
As of the fiscal period ended Wednesday, December 31, 2025. 13.52% above its 12-month average of 21.05%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
23.89%
RETURN ON ASSETS (ROA) AVG TTM
21.05%
RETURN ON ASSETS (ROA) AVG 3Y
19.32%
RETURN ON ASSETS (ROA) AVG 5Y
16.45%
RETURN ON ASSETS (ROA) AVG 10Y
10.88%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.52%
CURRENT VS 3Y AVG
+23.62%
CURRENT VS 5Y AVG
+45.21%
CURRENT VS 10Y AVG
+119.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+386.56%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$16.11B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$16.97B
Return on Assets (ROA)
5.92%
TTM Avg
7.45%
3Y Avg
8.56%
5Y Avg
11.79%
Market Cap
$14.80B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$14.10B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$18.17B
Return on Assets (ROA)
3.35%
TTM Avg
3.64%
3Y Avg
3.29%
5Y Avg
2.38%
Market Cap
$13.51B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$12.55B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$12.11B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $16.11B | 23.89% | 21.05% | 19.32% | 16.45% |
| DaVita Inc. (DVA)vs › | $15.41B | 4.47% | 4.84% | 4.27% | 4.56% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Solventum Corporation (SOLV)vs › | $14.80B | 10.16% | 7.10% | 8.43% | 7.35% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 1.89% | 3.10% | 3.02% | 7.71% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 3.35% | 3.64% | 3.29% | 2.38% |
| Baxter International Inc. (BAX)vs › | $13.51B | -5.37% | -3.64% | -1.62% | 0.47% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 6.44% | 6.68% | 6.69% | 12.75% |
| Viatris Inc. (VTRS)vs › | $20.45B | -0.80% | -5.49% | -1.68% | -1.68% |
ROA
23.9%
ROE
113.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 22.84% |
| 2024-12-31 | 19.25% |
| 2023-12-31 | 17.07% |
| 2022-12-31 | 18.14% |
| 2021-12-31 | 10.96% |
| 2020-12-31 | 10.45% |
| 2019-12-31 | 8.79% |
| 2018-12-31 | 7.56% |
| 2017-12-31 | 4.11% |
| 2016-12-31 | 1.37% |
| 2015-12-31 | -0.88% |
| 2014-12-31 | -1.42% |
| 2013-12-31 | 0.00% |
